Condensed Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Operating expenses
Research and development	$ 7,321	$ 2,254	$ 13,306	$ 4,832
General and administrative	3,090	1,187	6,312	2,402
Total operating expenses	10,411	3,441	19,618	7,234
Loss from operations	(10,411)	(3,441)	(19,618)	(7,234)
Other income (expense)
Interest income, net	260	4	337	8
Change in fair value of preferred stock tranche rights liability and preferred stock warrant liability		(57,940)		(81,157)
Other income, net	0	19	1	28
Total other income (expense)	260	(57,917)	338	(81,121)
Net loss	(10,151)	(61,358)	(19,280)	(88,355)
Other comprehensive loss
Unrealized loss on marketable securities	(151)		(734)
Comprehensive loss	$ (10,302)	$ (61,358)	$ (20,014)	$ (88,355)
Net loss per common share, basic	$ (0.25)	$ (141.93)	$ (0.48)	$ (207.52)
Net loss per common share, diluted	$ (0.25)	$ (141.93)	$ (0.48)	$ (207.52)
Weighted-average shares outstanding, basic	40,497,087	432,325	40,485,244	425,761
Weighted-average shares outstanding, diluted	40,497,087	432,325	40,485,244	425,761